As a consequence, several groups investigated the biomarker role of interleukins in several phases of oral cancer progression, and IL-1-β, IL-6, and IL-8 resulted in potentially predictive salivary biomarkers of OSCC progression [51]. The gene discussed is IL6; the disease is lip and oral cavity carcinoma.